BusinessActinium Pharmaceuticals Highlights Data at the American Society of Hematology Annual Meeting Showing CD33 Expression in a Significant Number of Multiple Myeloma Patients Supporting the Rationale for Actimab-MBy Nasdaq OMXDec 11, 2017, 9:15 PM UTC
BusinessNew Research Study Demonstrates Applicability of VisionGate’s 3-Dimensional Cell-CT™ Imaging and Analysis PlatformBy Nasdaq OMXDec 11, 2017, 8:27 PM UTC
BusinessFree Seminar for Healthcare Providers on Breast Cancer in Young WomenBy Nasdaq OMXDec 11, 2017, 6:40 PM UTC
BusinessClinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated Safety ProfileBy Nasdaq OMXDec 11, 2017, 3:00 PM UTC
BusinessCombination of G100 with KEYTRUDA (pembrolizumab) Triggers Robust Systemic Responses in Follicular NHL PatientsBy Nasdaq OMXDec 10, 2017, 2:00 PM UTC
BusinessCrown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer PharmacologyBy Nasdaq OMXDec 7, 2017, 3:36 PM UTC
BusinessUPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical TrialsBy Nasdaq OMXDec 5, 2017, 5:35 PM UTC
BusinessRich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical TrialsBy Nasdaq OMXDec 5, 2017, 3:35 PM UTC
